Mirjana Ziemer
Leipzig, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 11, 2026
Serum lactate dehydrogenase is associated with the presence and extent of preoperative peritumoral edema in melanoma brain metastases.
Journal: Journal of neuro-oncology
Published: May 15, 2026
Diagnostic Accuracy of Ex Vivo Confocal Laser Scanning Microscopy for Routine Detection of Cutaneous Squamous Cell Carcinoma and Actinic Keratoses.
Journal: Cancers
Published: March 02, 2026
Successful checkpoint inhibition plus extracorporeal photopheresis in patients with metastatic melanoma and advanced Sézary syndrome
Journal: Dermatologie (Heidelberg, Germany)
Published: January 02, 2026
S1 guideline sweat gland carcinoma.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: September 28, 2025
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 18, 2025
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial.
Journal: The British journal of dermatology
Published: April 08, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 31, 2025
Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial.
Journal: ESMO open
Published: January 30, 2025
Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors.
Journal: Cancer communications (London, England)
Published: January 24, 2025
Last Updated: 09/26/2026